8143.HK stock plunged 28.57% pre-market to HKD 0.10 on 17,031,600 shares, making it one of Hong Kong’s top pre-market losers. The move follows heavy trading against a weak earnings backdrop: EPS -0.03 and a negative PE -3.33. Investors should note the liquidity spike — volume is roughly 20.90x the average — and weigh short-term volatility against the company’s small market cap in Hong Kong (HKD 112,729,998.00).

Price action and pre-market context for 8143.HK stock

The stock opened at HKD 0.14 and slid to HKD 0.10 in pre-market trade, with a day range so far of HKD 0.099–0.145. The relative volume 20.90 and reported volume 17,031,600 show a clear liquidity-driven sell-off.

Fundamentals and valuation — 8143.HK analysis

Good Fellow Healthcare (8143.HK, HKSE) reports trailing revenue per share HKD 0.02 and net income per share HKD -0.02. Key ratios include PB 8.27, P/S 6.51, and current ratio 10.27, indicating ample short-term liquidity but stretched market valuation relative to book.

Technicals and volume signals

RSI sits near 52.04, while ADX 44.34 signals a strong trend. Bollinger bands are 0.08–0.19, and the stock trades well below its 50- and 200-day averages (both ~HKD 0.15), reinforcing the short-term downtrend.

Meyka Stock Grade and model forecast

Meyka AI rates 8143.HK with a score out of 100: 62.49, Grade B, Suggestion HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, metrics, forecasts and analyst consensus. Meyka AI’s forecast model projects a monthly target HKD 0.12 and a quarterly target HKD 0.18. Forecasts are model-based projections and not guarantees.

Catalysts, sector context and risks

Good Fellow operates general hospitals in China and sits in the Healthcare, Medical – Care Facilities industry, where peers show stronger margins. Key risks: small market cap (HKD 112,729,998.00), negative earnings, high PB and low profitability metrics (ROE -5.74%). Potential catalysts include hospital management contracts or disposal/asset moves announced via HKEX disclosures.

Trading considerations and price targets

For traders, watch liquidity and 50-day average HKD 0.15 as resistance. Meyka suggests a conservative near-term price target HKD 0.06 (capital-protection scenario) and an upside scenario HKD 0.18 if sentiment and operations improve. Position sizing is critical given high intraday volatility.

Final Thoughts

Key takeaways on 8143.HK stock: the pre-market 28.57% drop to HKD 0.10 came with 17,031,600 shares traded and relative volume 20.90, a clear liquidity-driven move. Fundamentals remain weak: EPS -0.03, PE -3.33, high PB 8.27 and negative ROE -5.74%. Meyka AI’s forecast model projects HKD 0.12 (monthly) and HKD 0.18 (quarterly); the quarterly figure implies an 80.00% upside from the current price, while the annual projection implies downside. These model projections are not guarantees. Given the grade (Meyka: 62.49, Grade B, Suggestion HOLD) and material valuation risks, cautious traders may wait for clearer operational news or a return to volumes near the 814,764 average before adding exposure. For disclosures and company updates check the company site and HKEX notices for confirmation of catalysts and announcements. source source

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.